MedPath

Investigation of complement activity between generic drug and barand-name drug for the use of anticoagulant during blood apheresis therapy

Not Applicable
Conditions
Sepsis
Registration Number
JPRN-UMIN000029038
Lead Sponsor
Shiga University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

age under 20 y.o.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The difference of the complement activity with the use of brand name drug or generic drug
Secondary Outcome Measures
NameTimeMethod
The difference of the coagulation activity or cytokine concentration with the use of brand name drug or generic drug
© Copyright 2025. All Rights Reserved by MedPath